Asset Management One
CPRX

Asset Management One’s Catalyst Pharmaceutical CPRX Stock Holding History

Asset Management One’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,613
Closed -$111K – 923
2025
Q4 		$111K Buy
+4,613
New +$103K ﹤0.01% 906
2023
Q3 		– Sell
-12,506
Closed -$168K – 999
2023
Q2 		$168K Buy
+12,506
New +$180K ﹤0.01% 919

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Asset Management One's CPRX Position: Q1 2026 in Review

Asset Management One sold out of Catalyst Pharmaceutical (CPRX) in Q1 2026, closing a stake of 4,613 shares — an estimated $111K sold.

Asset Management One first reported a position in CPRX in Q2 2023 and held it in 2 quarters. The position peaked at $168K in Q2 2023. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Asset Management One reported no remaining Catalyst Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Asset Management One sold 4,613 Catalyst Pharmaceutical shares in Q1 2026, an estimated $111K.
  • Asset Management One first reported a position in Catalyst Pharmaceutical in Q2 2023 and held it in 2 quarters.
  • Asset Management One's Catalyst Pharmaceutical position peaked at $168K in Q2 2023.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Asset Management One's 13F filing for Q1 2026, filed 8 May 2026.